Cargando…
SARS-CoV2 antibody response after a third dose of heterologous ChAdOx1 nCoV-19 and Moderna vaccine in chronic dialysis patients
Autores principales: | Cheng, Chung-Yi, Hsiao, Shih-Hsin, Fang, Te-Chao, Lin, Yen-Chung, Wang, Jude Chu-Chun, Hung, Ching-Sheng, Chen, Tso-Hsiao, Sue, Yuh-Mou |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The British Infection Association. Published by Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988583/ https://www.ncbi.nlm.nih.gov/pubmed/35398405 http://dx.doi.org/10.1016/j.jinf.2022.04.011 |
Ejemplares similares
-
The Humoral Immune Response of the ChAdOx1 nCoV-19 Vaccine in Maintenance Dialysis Patients without Prior COVID-19 Infection
por: Cheng, Chung-Yi, et al.
Publicado: (2022) -
Heterologous ChAdOx1 nCoV-19 and mRNA-1273 Vaccination
por: Normark, Johan, et al.
Publicado: (2021) -
Immunogenicity and reactogenicity of heterologous ChAdOx1 nCoV-19/mRNA vaccination
por: Schmidt, Tina, et al.
Publicado: (2021) -
Humoral Immunogenicity and Reactogenicity of the Standard ChAdOx1 nCoV-19 Vaccination in Taiwan
por: Chang, Jer-Hwa, et al.
Publicado: (2022) -
ChAdOx1 nCoV-19 vaccine for SARS-CoV-2
por: Lodge, Archie
Publicado: (2020)